A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab

Rheumatology International

Volumn 28, Issue 11, 2008, Pages 1155-1159

  Kuroda, Takeshi ^a   Otaki, Yasuhiro ^a   Sato, Hiroe ^a   Fujimura, Takeo ^a   Nakatsue, Takeshi ^a   Murakami, Syuichi ^a   Sakatsume, Minoru ^a   Nakano, Masaaki ^b   Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

AA amyloidosis; Gastrointestinal amyloidosis; Infliximab; Renal function; Rheumatoid arthritis

Indexed keywords

AMYLOID A PROTEIN; AUROTHIOMALATE; BUCILLAMINE; CREATININE; INFLIXIMAB; METHOTREXATE; PREDNISOLONE;

AA AMYLOIDOSIS; ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; CREATININE CLEARANCE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL BIOPSY; HUMAN; HUMAN TISSUE; JAPANESE; KIDNEY BIOPSY; LABORATORY TEST; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

AMYLOIDOSIS; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MIDDLE AGED; NEPHROTIC SYNDROME; SERUM AMYLOID A PROTEIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 49649101284     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0590-z     Document Type: Article

References (26)

1. GG Glenner 1980 Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts) N Engl J Med 302 1283 1292
2. A Suzuki Y Ohoshone M Obana S Mita Y Matsuoka S Irimajiri J Fukuda 1994 Cause of death in 81 autopsied patients with rheumatoid arthritis J Rheumatol 21 33 36
3. C Rocken A Shakespeare 2002 Pathology, diagnosis and pathogenesis of AA amyloidosis Virchows Arch 440 111 122
4. H Kobayashi S Tada T Fuchigami Y Okuda K Takasugi T Matsumoto M Iida K Aovagi A Iwashita Y Daimaru M Fujishima 1996 Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy Br J Rheumatol 35 44 49
5. T Kuroda N Tanabe T Harada S Murakami H Hasegawa M Sakatsume M Nakano F Gejyo 2006 Long term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis Clin Rheumatol 25 498 505
6. T Kuroda N Tanabe H Sato J Ajiro Y Wada S Murakami H Hasegawa M Sakatsume M Nakano F Gejyo 2006 Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatment Rheum Int 26 1147 1153
7. JD Gillmore LB Lovat MR Persey MB Pepys PN Hawkins 2001 Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein Lancet 358 24 29
8. M Ahlmen J Ahlmen C Svalander H Bucht 1987 Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency Clin Rheumatol 6 27 38
9. JE Gottenberg F Merle-Vincent F Bentaberry Y Allanore F Berenbaum B Fautrel B Combe A Durbach J Sibilia M Dougados X Mariette 2003 Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy Arthritis Rheum 48 2019 2024
10. O Elkayam PN Hawkins H Lachmann M Yaron D Caspi 2002 Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab Arthritis Rheum 46 2571 2573
11. G Husby 1985 Amyloidosis and rheumatoid arthritis Clin Exp Rheumatol 3 173 180
12. T Kuroda N Tanabe M Sakatsume S Nozawa T Mitsuka H Ishikawa CT Tohyama K Nakazono A Murasawa M Nakano F Gejyo 2002 Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis Clin Rheumatol 21 123 128
13. M Nakano M Ueno S Nishi H Shimada H Hasegawa T Watanabe T Kuroda T Sato Y Maruyama M Arakawa 1998 Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis Clin Nephrol 50 154 160
14. GR Smith KE Tymms M Falk 2004 Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis Intern Med J 34 570 572
15. S Urieli-Shoval RP Linke Y Matzner 2000 Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states Curr Opin Hematol 7 64 69
16. TA Niewold E Gruys R Kisilevsky TS Shirahama 1991 Fibril amyloid enhancing factor (FAEF)-accelerated amyloidosis in the hamster is not dependent on serine esterase activity and mononuclear phagocytosis Scand J Immunol 34 101 107
17. N Tanaka H Yonekura S Yamagishi H Fujimori Y Yamamoto H Yamamoto 2000 The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells J Biol Chem 275 25781 25790
18. SD Yan H Zhu A Zhu A Golabek H Du A Roher J Yu C Soto AM Schmidt D Stern M Kindy 2000 Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis Nat Med 6 643 651
19. DC Kluth AJ Rees 1999 New approach to modify glomerular inflammation J Nephrol 12 66 75
20. MG Suranyi A Guasch BM Hall BD Myers 1993 Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans Am J Kidney Dis 21 251 259
21. ET McCarthy R Sharma M Sharma JZ Li XL Ge KN Dileepan VJ Savin 1998 TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide J Am Soc Nephrol 9 433 438
22. Y Okuda K Takasugi 2006 Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis Arthritis Rheum 54 2997 3000
23. P Verschueren F Lensen E Lerut K Claes R De Vos B Van Damme R Westhovens 2003 Benefit of anti-TNFalpha treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis Ann Rheum Dis 62 368 369
24. MB Stokes K Foster GS Markowitz F Ebrahimi W Hines D Kaufman B Moore D Wolde VD D'Agati 2005 Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis Nephrol Dial Transplant 20 1400 1406
25. G Chin G Luxton JM Harvey 2005 Infliximab and nephrotic syndrome Nephrol Dial Transplant 20 2824 2826
26. N Shakoor M Michalska CA Harris JA Block 2002 Drug-induced systemic lupus erythematosus associated with etanercept therapy Lancet 359 579 580